Medicare Industries is the India based pharmaceutical company which focus on producing highest quality bulk drug with robust manufacturing facility. Medicare Industries is a leading, vertically integrated pharmaceutical manufacturing company which produce some of the highly sensitive products like Montelukast and Lisinopril with highest quality possible. We are committed to challenging the unmet medical and collective needs through a comprehensive pharmaceutical value chain spanning across the world.Every Medicare product is testament to its uncompromising quality standards. All products are manufactured in facilities that are approved by major global regulatory agencies. Today, a segment-leading pipeline and strong in-house development capabilities allow us to compete with some of the biggest portfolios in the industry.
Acebrophylline is a bronchodilator indicated in the symptomatic treatment of bronchopulmonary disorders associated with bronchospasm. Acebrophylline is prescribed to reduce the irritation, swelling, and narrowing of the bronchial tubes in patients with asthma, severe or chronic bronchitis, chronic obstructive pulmonary disease (COPD)and tightness of the chest. It helps in reducing the viscosity of the mucus in the airway and facilitates breathing.
Ship in 10 & 25Kg drums. Not hazardous product for transportation.
Product Name: | Acebrophylline |
---|---|
Chemical Name: | 2-(1,3-dimethyl-2,6-dioxopurin-7-yl) acetic acid |
Molecular Formula: | C22H28Br2N6O5 |
Relative Molecular Mass: | 616.311 |
Melting range: | 213-215°C |
CAS No: | 969899-76-3 |
PH | N/A |
Levocetirizine is an H1-receptor antagonist used to treat symptoms associated with chronic allergic rhinitis and uncomplicated cases of chronic idiopathic urticaria. Levocetirizine is a selective histamine H1 antagonist used to treat a variety of allergic symptoms. It is the R enantiomer of cetirizine. Levocetirizine has greater affinity for the histamine H1 receptor than cetirizine.
Ship in 5,10 & 25Kg drums. Not hazardous product for transportation.
Product Name: | Levocetirizine Hydrochloride |
---|---|
Molecular Formula: | C21H25ClN2O3 |
Relative Molecular Mass: | 461.8 |
CAS No: | 130018-87-0 |
PH | N/A |
Lisinopril is an ACE inhibitor used to treat hypertension, heart failure, and acute myocardial infarction. Lisinopril is an angiotensin converting enzyme inhibitor (ACEI) used to treat hypertension, heart failure, and myocardial infarction. Lisinopril and captopril are the only ACEIs that are not prodrugs. It functions by inhibition of angiotensin converting enzyme as well as the renin angiotensin aldosterone system. ACEIs are commonly used as a first line therapy in the treatment of hypertension, along with thiazide diuretics or beta blockers.
Ship in 5,10 & 25Kg drums. Not hazardous product for transportation.
Product Name: | Lisinopril |
---|---|
Chemical Name: | (S)-1-[N2-(1-carboxy-3-phenylpropyl)-L lysyl]-L-proline dihydrate |
Molecular Formula: | C21H31N3O5, 2H2O |
Relative Molecular Mass: | 441.5 |
CAS No: | 83915-83-7 |
PH | N/A |
Ambroxol is a medication indicated for airway secretion clearance therapy. It is a secretolytic agent used in the treatment of respiratory diseases associated with viscid or excessive mucus. It is the active ingredient of Mucosolvan, Lasolvan or Mucoangin. The substance is a mucoactive drug with several properties including secretolytic and secretomotoric actions that restore the physiological clearance mechanisms of the respiratory tract which play an important role in the body’s natural defence mechanisms. It stimulates synthesis and release of surfactant by type II pneumocytes. Surfactants acts as an anti-glue factor by reducing the adhesion of mucus to the bronchial wall, in improving its transport and in providing protection against infection and irritating agents.
Ship in 10 & 25Kg drums. Not hazardous product for transportation.
Product Name: | Ambroxol Hydrochloride |
---|---|
Molecular Formula: | C13H18Br2N2O, HCL |
Relative Molecular Mass: | 414.56 |
CAS No: | 23828-92-4 |
PH | 4.5 – 6.0 |
Montelukast is a leukotriene receptor antagonist used as part of an asthma therapy regimen, to prevent exercise induced bronchoconstriction, and to treat seasonal allergic rhinitis. Montelukast was first approved for clinical use by the US FDA in 1998 as Merck's brand name Singulair. The medication is a member of the leukotriene receptor antagonist (LTRA) category of drugs. Although capable of demonstrating effectiveness, the use of such LTRAs like montelukast is typically in addition to or complementary with the use of inhaled corticosteroids or other agents in asthma step therapy. Regardless, in 2008-2009, there were FDA-led investigations into the possibility of montelukast to elicit neuropsychiatric effects like agitation, hallucinations, suicidal behaviour, and others in individuals who used the medication. And although these kinds of effects are currently included in the official prescribing information for montelukast, the drug still sees extensive use worldwide via millions of prescriptions annually and has since become available as a generic and as a brand name product.
Ship in 5,10 & 25Kg drums. Not hazardous product for transportation.
Product Name: | Montelukast Sodium |
---|---|
Molecular Formula: | C35H35ClNNaO3S C21H31N3O5 |
Relative Molecular Mass: | 608.2 |
CAS No: | 151767-02-1 |
UNII: | U1O3J18SFL |
PH | N/A |
Code Mantra, © Copyright 2024. All Rights Reserved.